On Tuesday, October 3, 2023, shares of Ultragenyx Pharmaceutical Inc. (Symbol: RARE) entered oversold territory with a Relative Strength Index (RSI) reading of 29.96, indicating potential buy opportunities for investors. The stock exchanged hands at a low of $47.34 per share, compared to the S&P 500 ETF’s current RSI of 51.8.
RARE’s 52-week trading range has seen a low of $45.20 and a high of $104.38, with the last trade recorded at $47.54. The RSI reading suggests that heavy selling may be exhausting, prompting some investors to consider entry points for purchasing the stock.
